The effects of terpenes on the permeation of lidocaine and ofloxacin from moisture-activated patches

Drug Delivery

Volumn 16, Issue 2, 2009, Pages 75-81

  Song, Yeon Hwa ^a   Gwak, Hye Sun ^b   Chun, In Koo ^a  

^a Dongduk Women's University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Lidocaine; Moisture activated patches; Ofloxacin; Terpenes

Indexed keywords

CINEOLE; LIDOCAINE; LIMONENE; MENTHOL; OFLOXACIN; TERPENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; MALE; MOISTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SAFETY; SKIN PERMEABILITY;

ACRYLIC RESINS; ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CELLULOSE; CYCLOHEXANOLS; CYCLOHEXENES; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HYDROGELS; LIDOCAINE; MALE; MALEATES; MENTHOL; MICE; MICE, HAIRLESS; MONOTERPENES; OFLOXACIN; POLYETHYLENES; POLYSORBATES; SKIN ABSORPTION; TERPENES;

EID: 62249215079     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802586667     Document Type: Article

References (16)

1. Barry BW (1983). Dermatological Formulations. 49-94. New York, Marcel Dekker.
2. Chien YW and Lambert H J (1974). Controlled drug release from polymeric delivery devices. II. Differentiation between partition-controlled and matrix-controlled drug release mechanism. J. Pharm. Sci. 63, 515-519.
3. Gwak HS, Song YH and Chun IK (2005). Preparation and release properties of oromucosal moisture-activated patches containing lidocaine or ofloxacin. J. Kor. Pharm. Sci. 35, 417-422.
4. Hori M, Satoh S,Maibach HI and Gug R (1991). Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci. 80, 32-35.
5. Ishida M, Nambu N and Nagai T (1982). Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and Carbopol. Chem. Pharm. Bull. 30, 980-984.
6. Jain AK, Thomas NS and Panchagnula R (2002). Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J. Contr. Rel. 79, 93-101.
7. McCafferty DF and Woolfson A D (1993). New patch delivery system for percutaneous local anaesthesia. Br. J. Anaesth. 71, 370-374.
8. McCafferty DF, Woolfson AD and Moss G P (2000). Novel bioadhesive delivery system for percutaneous local anaesthesia. Br. J. Anaesth. 84, 456-458.
9. Moghimi H, Williams A and Barry B (1997). A lamellar matrix model for stratum corneum intercellular lipids. V. Effects of terpene penetration enhancers on the structure and thermal behavior of the matrix. Int. J. Pharm. 146, 41-54.
10. Okamoto H, Hashida M and Sezaki H (1988). Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers. J. Pharm. Sci. 77, 418-424.
11. Petri WA Jr (2001). Antimicrobial agents: sulfonamides trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Goodman & Gilman's the pharmacological basis of therapeutics, eds. Hardman JG and Limbird L E 1171-1188. New York, McGraw Hill.
12. Sasaki H, Kojima M, Mori Y Nakamura J J, and Shibasaki (1991). Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen. J. Pharm. Sci. 80, 533-538.
13. Vaddi HK, Ho PC and Chan S Y (2002). Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, fourier transform infrared spectroscopy, and differential scanning calorimetry. J. Pharm. Sci. 91, 1639-1651.
14. Williams AC and Barry B W (1991). Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm. Res. 8, 17-24.
15. Woolfson AD, McCafferty DF and Boston V (1990). Clinical experiences with a novel percutaneous amethocaine preparation: prevention of pain due to venepuncture in children. Br. J. Clin. Pharmacol. 30, 273-279.
16. Woolfson AD, McCafferty DF and Moss GP (1998). Development and characterization of a moisture-activated bioadhesive drug delivery system for percutaneous local anaesthesia. Int. J. Pharm. 169, 83-94.